Price $0.03 |
Market Cap
5.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
24.8
|
P/B
0.96
|
P/S
1.95
|
Dividend %
-
|
|
P/CF
13.8
|
P/FCF
7.6
|
Op. Cash Flow
800
|
FCF
0.0
|
|
Op. Margin
30.20%
|
Net Margin
7.90%
|
ROE
3.90%
|
ROI
4.50%
|
|
ROA
1.50%
|
EPS Growth
173.70%
|
Current Ratio
3.4
|
Debt/Equity
84.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $108.39 | - | - | 8.13B | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.45 | - | - | 4.1M | Strong Buy |
| Spruce Biosciences Inc (SPRB) | $0.46 | - | - | 45.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
